Browsing "6. Others (기타)" by Title :

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 350 to 369 of 964

This table browses all dspace content
Issue DateTitleJournal Title
2021Paediatric palliative screening scale as a useful tool for clinicians' assessment of palliative care needs of pediatric patients: a retrospective cohort study BMC PALLIATIVE CARE
2015Pathologic Outcomes in Men with Low-risk Prostate Cancer Who Are Potential Candidates for Contemporary, Active Surveillance Protocols. JOURNAL OF KOREAN MEDICAL SCIENCE
2022Performance of clinician prediction of survival in oncology outpatients with advanced cancer PLOS ONE
2022Performance of mid-upper arm circumference and other prognostic indices based on inflammation and nutrition in oncology outpatients: a tertiary cancer center study ANNALS OF PALLIATIVE MEDICINE
2022Periodontal disease could be a potential risk factor for non-alcoholic fatty liver disease: An 11-year retrospective follow-up studyCLINICAL ORAL INVESTIGATIONS
2009Permanent pacemaker for syncope after heart transplantation with bicaval technique YONSEI MEDICAL JOURNAL
2019PET imaging of HER2 expression with an 18F-fluoride labeled aptamer PLOS ONE
2020Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects Translational and Clinical Pharmacology
2023Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter-2 inhibitor, with phentermine in healthy subjectsExpert Opinion on Drug Metabolism & Toxicology
2017Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers Transl Clin Pharmacol
2015Pharmacokinetic Interaction Between Amlodipine and Lobeglitazone, a Novel Peroxisome Proliferator–activated Receptor-γ Agonist, in Healthy SubjectsCLINICAL THERAPEUTICS
2017Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis DRUG DESIGN DEVELOPMENT AND THERAPY
2021Pharmacokinetics and safety of evogliptin in hepatically impaired patientsBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2016Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects DRUG DESIGN DEVELOPMENT AND THERAPY
2018Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans Korean J Physiol Pharmacol
2024Population pharmacokinetic-pharmacodynamic modeling of clopidogrel for dose regimen optimization based on CYP2C19 phenotypes: A proof of concept study CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY
2021Population Pharmacokinetics of Primaquine in the Korean Population PHARMACEUTICS
2017Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation SCIENTIFIC REPORTS
2020Positivity of Carbapenemase-producing Enterobacteriaceae in Patients Following Exposure within Long-term Care Facilities in Seoul, Korea JOURNAL OF KOREAN MEDICAL SCIENCE
2009Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseasesJOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Browse

Links